Trials / Completed
CompletedNCT04602949
Detection of COVID-19 Using Breath Analysis - Validation Study
Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,558 (actual)
- Sponsor
- Scentech Medical Technologies Ltd · Industry
- Sex
- All
- Age
- 6 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY
Detailed description
A diagnostic prospective single-site study, with no anticipated risks or constraints. Primary objective- To validate the value of a set of breath VOC biomarkers that enable us to distinguish between Coronavirus (SARS-CoV-2) carriers and SARS-CoV-2-negative in comparison to the gold-standard testing methodology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Breath Biopsy Analysis | Analysis of a single breath Biopsy |
Timeline
- Start date
- 2020-11-12
- Primary completion
- 2022-05-28
- Completion
- 2023-01-18
- First posted
- 2020-10-26
- Last updated
- 2023-05-16
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04602949. Inclusion in this directory is not an endorsement.